Venus Remedies gets market authorisation for Bleomycin 15,000 IU in the UK EP News Bureau Oct 26, 2023 Venus Remedies holds a total of 15 MA for Bleomycin products across the globe
SII seeks market authorisation from DCGI for India’s first qHPV vaccine against cervical cancer Press Trust of India Jun 10, 2022 The firm has applied for market authorisation after completing the phase-II/III clinical trial with support of the Department of…
